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Short Communication
Is folate absorption impaired by high dose methotrexate?
C.R. Pinkerton*
Department ofChild Health, Institute ofChild Health, Guilford Street, London WCJ.
The use of high dose methotrexate (MTX) in the
management of solid and haematological
malignancies is currently under investigation in a
number of clinical trials. Citrovorum rescue (CVR)
is an essential part of such therapy. Given at an
interval after MTX folinic acid reverses the
cytotoxic effect and prevents the otherwise
inevitable bone marrow and intestinal toxicity
caused by prolonged high serum MTX
concentrations (Djerassi, 1975). In recent protocols
CVR is given 6-8 hourly commencing 24h after
MTX (UK Childrens Cancer Study Group, 1977,
unpublished). At least the first dose is given
intravenously to ensure adequate blood levels and
subsequent doses are given either orally or
intramuscularly. Although some protocols do not
involve parenteral CVR there has been a general
reluctance to rely on oral administration even in the
absence of clear contraindications such as vomiting
or intolerance. One reason for this reluctance is the
possibility that the acute toxic effect of MTX on the
small gut might impair folate absorption and reduce
the efficacy of rescue. The most severe structural
and functional abnormalities in the small gut are
evident 2-4 days after MTX and are usually
associated with villos atrophy. Although such
abnormalities are prevented by CVR early acute
changes in enterocyte morphology and metabolism
have been described within 6h of drug
administration. (Vitale et al., 1954; Trier, 1962). Such
abnormalities could impair absorption and make
oral CVR inadvisable. To test this hypothesis small
intestinal absorption was studied in the rat after
high dose MTX. Direct estimation of folinic acid
absorption was not possible due to the non-
availability of a suitable isotope-labelled
preparation. Folic acid has, however, been shown to
share the absorption mechanism (Rosenberg, 1975)
and this structural analogue was used instead.
Male Wistar rats weighing 250-300g were fasted
for 16h prior to study; water was freely available.
Treated animals were given a single injection
(50mgkg 1) of MTX (Lederle) into a tail vein. Age-
and weight-matched controls received a similar
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volume of i.v. saline. At either 4 or 24h after
injection the animals were anaesthetised and a
segment of proximal jejunum isolated and perfused
using the continuous perfusion technique (Sladen &
Harries, 1972). A perfusion rate of 0.2mlmin- was
used and the effluent collected over 3 consecutive
20min periods after a 50 min equilibration period.
The perfusate contained NaCl (145mM 1-i) KCI
(4mM1-'), NaHCO3 (25mMl-), polyethylene
glycol (PEG 4000) 3gl- with 40uCi [i4C] PEG
(Radiochemical Centre, Amsterdam) and folic acid
0.44mgl-i (10-6M) with l5YCi [3H] folic acid. pH
was adjusted to 7 with CO2 and the osmolality of
the solution was 290mosmkg-'.
The initial perfusate solution and the effluent
were analysed for sodium by flame photometry and
glucose by colorimetric assay; [i4C] and [3H]
concentrations were measured in 200p aliquots in
RIA Luma scintillant (LKB) using an LKB Wallac
scintillation counter. Absorption rates (per g wet
tissue weight) of water, sodium, glucose and folic
acid were calculated using PEG as a non-
absorbable marker (Sladen & Dawson, 1969).
Villos architecture was unaltered within 24h of
MTX. Mean villos height (340+26pm) and crypt
depth (172+12pm) did not differ from controls (357
+6 and 174+5pm respectively). The effect of high
dose MTX onjejunal absorption is illustrated in the
Figure. At 4h there was no significant alteration in
the absorption of water or solutes but at 24h the
absorption of water and sodium was significantly
increased. (P<0.05, Students t test). This was
accompanied by a similar increase in folic acid
absorption (P<0.05). Glucose absorption at 4 and
24h (means 0.28+0.05 and 0.35+01 puMg-i min1
respectively) did not differ significantly from saline-
injected controls (0.27+0.04 Mg- min- ).
Electron microscopic studies of jejunal mucosa
from adults with psoriasis reveal patchy enterocyte
vacuolation within 6h of 2mgkg-' i.v. MTX (Trier,
1962). Similar ultrastructural changes were seen in
children with acute leukaemia after oral MTX
(15mgm-2) (Gwavava et al., 1981). These
abnormalities are unrelated to the primary action of
MTX which affects the rapidly-dividing crypt cell
population and are probably due to the action of
the drug on protein and RNA synthesis-a
consequence of impaired one carbon transfer.
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Figure Jejunal absorption of water, sodium and folic acid 4 and 24h after MTX (50mgkg 1, i.v.) compared
with saline-injected controls.
(Delmonte & Jukes, 1962) The functional effects of toxicity could be responsible for such MTX-induced
methotrexate enterotoxicity have been widely malabsorption. A local toxic effect on villos cells
studied in the experimental animal (Shaw et al., might be a consequence of the high biliary
1979, Capel et al., 1979, Taminiau et al., 1980) but concentrations of MTX after high dose therapy
absorption has been measured when there was (Halsted, 1972). MTX also lowers intestinal mucosal
severe villos atrophy and dysfunction was pH and impairs folate uptake (Lei et al., 1977) and
therefore to be expected. The present study was luminal MTX could compete with folate at the site
designed to determine whether high dose MTX of active transport (Selhub et al., 1973). The present
influenced absorptive function in the absence of study, however, demonstrates that despite these
villos atrophy and, in particular, whether folate possibilities high dose MTX does not impair folic
absorption was impaired. acid absorption and is therefore unlikely to
Two mechanisms are involved in folate absorption influence the absorption of the reduced form of
(Rosenberg, 1976). An energy-dependent, structure- folinic acid which shares the same mechanisms of
specific, saturable system which is shared by absorption. Moreover at 24h after MTX there was
unreduced, reduced and substituted monoglutamyl an increase in the absorption of water, sodium and
folates and a second passive mechanism that follows folic acid. It is of interest that Hoffbrand & Fry
the laws of diffusion. Kirwan et al. (1976) (1972) reported an apparent increase in folic acid
demonstrated that oral folinic acid absorption absorption after MTX although failure of tubular
compares well with the i.m. route but suggested that reabsorption was suggested to be the cause of high
MTX enterotoxicity might impair folate absorption. urinary folate levels after an oral loading test. It
A number of mechanisms other than direct systemic seems unlikely, that the active transport mechanism
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for folates is enhanced by the antimetabolite MTX,
so what is the likely mechanism of such increased
absorption?
In vitro animal studies have demonstrated altered
jejunal permeability after i.v. MTX (30mgkg-1)
(Taminiau, 1980) and pre-bone marrow transplant
chemotherapy also increased intestinal permeability
(Gomes et al., 1982). It has been postulated that
such changes are due to damage to mucosal
junctional complexes and an increase in the villos
tip extrusion zone (Pearson et al., 1982). It is
possible that the dilated intercellular spaces that
were described after low dose MTX were due to
increased water entry by this paracellular pathway
(Guavava et al., 1981). The enhanced absorption of
folic acid may be a secondary phenomenon due to
increased water and sodium uptake which
overcomes any inhibitory effect that MTX might
have upon active folate transport. An alternative
explanation is that MTX occupies intracellular
binding sites for folates thus reducing intracellular
persistence of folic acid and increasing the rate of
transmucosal passage. MTX has been shown to
reduce mucosal concentrations of folic acid and
enhance serosal to mucosal transport in everted
sacs of rat jejunum (Selhub et al., 1973).
In conclusion it seems likely that after high dose
parenteral MTX the absorption of folinic acid is at
least as good as in untreated cases and that oral
CVR is unlikely to be impaired.
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